These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24657963)

  • 1. Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.
    Fink KD; Crane AT; Lévêque X; Dues DJ; Huffman LD; Moore AC; Story DT; Dejonge RE; Antcliff A; Starski PA; Lu M; Lescaudron L; Rossignol J; Dunbar GL
    Stem Cells Transl Med; 2014 May; 3(5):620-31. PubMed ID: 24657963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum.
    Fink KD; Rossignol J; Lu M; Lévêque X; Hulse TD; Crane AT; Nerriere-Daguin V; Wyse RD; Starski PA; Schloop MT; Dues DJ; Witte SJ; Song C; Vallier L; Nguyen TH; Naveilhan P; Anegon I; Lescaudron L; Dunbar GL
    Cell Transplant; 2014; 23(11):1407-23. PubMed ID: 23879897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.
    Rossignol J; Boyer C; Lévèque X; Fink KD; Thinard R; Blanchard F; Dunbar GL; Lescaudron L
    Behav Brain Res; 2011 Mar; 217(2):369-78. PubMed ID: 21070819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model.
    Mu S; Wang J; Zhou G; Peng W; He Z; Zhao Z; Mo C; Qu J; Zhang J
    PLoS One; 2014; 9(7):e101185. PubMed ID: 25054283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profilin-2 increased expression and its altered interaction with β-actin in the striatum of 3-nitropropionic acid-induced Huntington's disease in rats.
    Chakraborty J; Pandey M; Navneet AK; Appukuttan TA; Varghese M; Sreetama SC; Rajamma U; Mohanakumar KP
    Neuroscience; 2014 Dec; 281():216-28. PubMed ID: 25255934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease.
    Shear DA; Dong J; Gundy CD; Haik-Creguer KL; Dunbar GL
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1217-40. PubMed ID: 9829299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral fetal striatal grafts in the 3-nitropropionic acid-induced hypoactive model of Huntington's disease.
    Borlongan CV; Koutouzis TK; Poulos SG; Saporta S; Sanberg PR
    Cell Transplant; 1998; 7(2):131-5. PubMed ID: 9588595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral striatal transplantation of human olfactory stem cells ameliorates motor function, prevents necroptosis-induced cell death and improves striatal volume in the rat model of Huntington's disease.
    Bayat AH; Saeidikhoo S; Ebrahimi V; Mesgar S; Joneidi M; Soltani R; Aghajanpour F; Mohammadzadeh I; Torabi A; Abdollahifar MA; Bagher Z; Alizadeh R; Aliaghaei A
    J Chem Neuroanat; 2021 Mar; 112():101903. PubMed ID: 33278568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.
    Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E
    Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
    Danduga RCSR; Dondapati SR; Kola PK; Grace L; Tadigiri RVB; Kanakaraju VK
    Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
    Reynolds DS; Carter RJ; Morton AJ
    J Neurosci; 1998 Dec; 18(23):10116-27. PubMed ID: 9822765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.
    McBride JL; During MJ; Wuu J; Chen EY; Leurgans SE; Kordower JH
    Exp Neurol; 2003 Jun; 181(2):213-23. PubMed ID: 12781994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
    Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
    Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats.
    Borlongan CV; Koutouzis TK; Randall TS; Freeman TB; Cahill DW; Sanberg PR
    Brain Res Bull; 1995; 36(6):549-56. PubMed ID: 7538873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levothyroxine attenuates behavioral impairment and improves oxidative stress and histological alteration 3-nitropropionic acid induced experimental Huntington's disease in rats.
    Badini F; Bayrami A; Mirshekar MA; Shahraki S; Fanaei H
    Behav Brain Res; 2024 Mar; 461():114864. PubMed ID: 38220060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington's disease in rats.
    Katariya R; Mishra K; Sammeta S; Umekar M; Kotagale N; Taksande B
    Neurotoxicology; 2024 May; 102():12-28. PubMed ID: 38453033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.
    Jeon I; Lee N; Li JY; Park IH; Park KS; Moon J; Shim SH; Choi C; Chang DJ; Kwon J; Oh SH; Shin DA; Kim HS; Do JT; Lee DR; Kim M; Kang KS; Daley GQ; Brundin P; Song J
    Stem Cells; 2012 Sep; 30(9):2054-62. PubMed ID: 22628015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study.
    Rodriguez AI; Willing AE; Saporta S; Cameron DF; Sanberg PR
    Neurotox Res; 2003; 5(6):443-50. PubMed ID: 14715448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease.
    Ryu JK; Kim J; Cho SJ; Hatori K; Nagai A; Choi HB; Lee MC; McLarnon JG; Kim SU
    Neurobiol Dis; 2004 Jun; 16(1):68-77. PubMed ID: 15207263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington's disease.
    Shehata NI; Abd El-Salam DM; Hussein RM; Rizk SM
    PLoS One; 2023; 18(11):e0293660. PubMed ID: 37910529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.